Centerline Biomedical Raised $33 Million for Product Innovation
Proceeds raised will accelerate a R&D pipeline, commercial partnerships, and clinical activities by strategic investors.
Proceeds raised will accelerate a R&D pipeline, commercial partnerships, and clinical activities by strategic investors.
Proceeds raised will accelerate a R&D pipeline, commercial partnerships, and clinical activities by strategic investors.